Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone

Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Frontiers in oncology·2026

Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Frontiers in oncology·2026

Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology.

NeuroImage·2025

Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.

ESMO open·2025

Use of morcellation in laparoscopic myomectomy. Medical malpractice and medicolegal considerations.

La Clinica terapeutica·2024

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Annals of hematology·2022

A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis.

Pharmacological research·2026

Cannabinoids as Context-Dependent Modulators of the Adenosine A3 Receptors: Potential Orthosteric and Allosteric Mechanisms.

Pharmacological research·2026

A RISKmilk framework for predicting drug and chemical exposure in human milk during breastfeeding.

Pharmacological research·2026

DHA in Alzheimer's Disease: The translational gap between mechanistic complexity and clinical inconsistency.

Pharmacological research·2026

IDO1 integrates gut microbiota-derived SCFAs signals and host WNT/TGF-β pathways to mediate the anti-colorectal cancer effects of licorice flavonoids.

Pharmacological research·2026

Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome-immune axis for cancer immunotherapy.

Pharmacological research·2026

Slow-cooked naive T cells make better effectors.

The Journal of experimental medicine·2026

Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations.

Human vaccines & immunotherapeutics·2026

Monoclonal antibodies raised against the Junín virus glycoprotein show broad reactivity and provide protection in vivo.

mBio·2026

Interferome profiling in the blood links IFNα5-Mucin-1 axis to HIV-1 pathogenesis.

Journal of virology·2026

Research Progress on Mechanisms of Immune Tolerance Induced by Hepatitis B Surface Antigen in Chronic HBV Infection.

Journal of immunology research·2026

Research progress on the role of IL‑37 in gynecological and obstetrics‑related diseases (Review).

International journal of molecular medicine·2026

Related Experiment Videos

Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone

Related Concept Videos

Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network.

Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology.

Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.

Use of morcellation in laparoscopic myomectomy. Medical malpractice and medicolegal considerations.

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

A small molecule ACT004 targets four-and-a-half LIM domain protein 1 to disrupt TGF-β/Smad signaling and promote FHL1 degradation in renal fibrosis.

Cannabinoids as Context-Dependent Modulators of the Adenosine A3 Receptors: Potential Orthosteric and Allosteric Mechanisms.

A RISKmilk framework for predicting drug and chemical exposure in human milk during breastfeeding.

DHA in Alzheimer's Disease: The translational gap between mechanistic complexity and clinical inconsistency.

IDO1 integrates gut microbiota-derived SCFAs signals and host WNT/TGF-β pathways to mediate the anti-colorectal cancer effects of licorice flavonoids.

Nanoparticle pharmacomicrobiomics: Reprogramming the microbiome-immune axis for cancer immunotherapy.

Slow-cooked naive T cells make better effectors.

Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations.

Monoclonal antibodies raised against the Junín virus glycoprotein show broad reactivity and provide protection in vivo.

Interferome profiling in the blood links IFNα5-Mucin-1 axis to HIV-1 pathogenesis.

Research Progress on Mechanisms of Immune Tolerance Induced by Hepatitis B Surface Antigen in Chronic HBV Infection.

Research progress on the role of IL‑37 in gynecological and obstetrics‑related diseases (Review).

Related Experiment Videos

Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone

Related Concept Videos

Related Articles